Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Internal analysis
Evaluating a company's strengths, weakness and opportunities with a study of the company’s internal marketing resources. A SWOT analysis is frequently used in Marketing Planning to ascertain the Strengths, Weaknesses, Opportunities, and Threats that are key factors for a company in predicting its future success.
See also:
SWOT analysis
Marketing planning
Related terms
Brand, Industrial marketing, Viral marketing, Test marketing, Marketing audit, Mathematical analysis of perception and preference (MAPP), Early majority, Leader pricing, Buzz, Monopoly, Clip or Clipping, Channel strategy, Internal marketing, Strategic business unit (SBU), Market share,
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Why pharma must get smart in its approach to customer engagement
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- GSK appoint Tony Wood as chief scientific officer
- Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
- SMC approves Parkinson’s disease treatment Ongentys
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- Home or away: where next for pharmaceutical symposia?
- PM announces plans to lift England’s COVID-19 restrictions
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Why pharma must get smart in its approach to customer engagement
- AstraZeneca's Enhertu receives FDA grant for priority review
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- Assessing the value of interim analyses in clinical trials
- European biotech: a new generation of leaders emerges
- A rough guide to... advisory boards
